Specific codes in ICD-10 are unique alphanumeric designations used to identify and categorize diseases, disorders, and conditions. They consist of 3-5 characters, including both letters and numbers, that provide a high level of detail and specificity.
| Language | Translation |
|---|---|
English
|
Thyrotoxicosis [hyperthyroidism] |
French
|
Thyréotoxicose [hyperthyroïdie] |
| Level | Code | Title | |
|---|---|---|---|
| 1 | IV | Endocrine, nutritional and metabolic diseases | |
| 2 | E00-E07 | Disorders of thyroid gland | |
| 3 | E05 | Thyrotoxicosis [hyperthyroidism] |
| Code | Title | |
|---|---|---|
| E05.0 | Thyrotoxicosis with diffuse goitre | |
| E05.1 | Thyrotoxicosis with toxic single thyroid nodule | |
| E05.2 | Thyrotoxicosis with toxic multinodular goitre | |
| E05.3 | Thyrotoxicosis from ectopic thyroid tissue | |
| E05.4 | Thyrotoxicosis factitia | |
| E05.5 | Thyroid crisis or storm | |
| E05.8 | Other thyrotoxicosis | |
| E05.9 | Thyrotoxicosis, unspecified |
| Active Ingredient | Description | |
|---|---|---|
| Propranolol |
Propranolol is a competitive antagonist at both beta, and beta2-adrenoceptor, but has membrane stabilising activity at concentrations exceeding 1-3mg/litre, though such concentrations are rarely achieved during oral therapy. Competitive beta-blockade has been demonstrated in man by a parallel shift to the right in the dose-heart rate response curve to beta-agonists such as isoprenaline. |
|
| Thiamazole |
Thiamazole inhibits dose-dependently the incorporation of iodine into tyrosine and thereby the neosynthesis of thyroid hormones. This property permits symptomatic therapy of hyperthyroidism regardless of its cause. |
